About
Technology
Issues
FAQ
Links
Official Page
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.